VERU INC
VERU · NASDAQ
Updated at 2026-10-15 08:28:24
- Today's High
- $2.29
- Today’s Low
- $2.11
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.26
- Previous Close
- $2.13
- Volume
- 275.18K
- Market Cap
- $36.31M
- P/E Ratio
- --
- EPS
- $-0.58
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 2916 NORTH MIAMI AVENUE, MIAMI, FL, UNITED STATES, 33127
- Country
- US
- Listing Date
- 1990-07-19
- Fiscal Year End
- September
- Shares Outstanding
- 16.05M
- CIK
- 0000863894
- Website
- verupharma.com
Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. The company is headquartered in Miami, Florida.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$56.38K
2025-12-31
$0
2025-09-30
$247.06K
Operating Expenses
2026-06-30
$7.71M
2026-03-31
$7.21M
2025-12-31
$5.39M
2025-09-30
-$1.16M
Net Income
2026-06-30
-$6.98M
2026-03-31
-$2.74M
2025-12-31
-$5.33M
2025-09-30
$1.45M
Net Profit Margin
2026-06-30
--
2026-03-31
-4.86K%
2025-12-31
--
2025-09-30
588.31%
Earnings Per Share
2026-06-30
$-0.30
2026-03-31
$-0.13
2025-12-31
$-0.26
2025-09-30
$0.09
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$6.96M
2026-03-31
-$7.19M
2025-12-31
-$5.39M
2025-09-30
-$7.43M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $56.38K | $0 | $247.06K |
| Operating Expenses | $7.71M | $7.21M | $5.39M | -$1.16M |
| Net Income | -$6.98M | -$2.74M | -$5.33M | $1.45M |
| Net Profit Margin | -- | -4.86K% | -- | 588.31% |
| Earnings Per Share | $-0.30 | $-0.13 | $-0.26 | $0.09 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$6.96M | -$7.19M | -$5.39M | -$7.43M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.